- Home
- CMPX vs GLDG Comparison
CMPX vs GLDG Comparison
Compare CMPX & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- GLDG
- Stock Information
- Founded
- CMPX 2014
- GLDG 2009
- Country
- CMPX United States
- GLDG Canada
- Employees
- CMPX N/A
- GLDG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- GLDG Precious Metals
- Sector
- CMPX Health Care
- GLDG Basic Materials
- Exchange
- CMPX Nasdaq
- GLDG Nasdaq
- Market Cap
- CMPX 730.9M
- GLDG 317.0M
- IPO Year
- CMPX N/A
- GLDG N/A
- Fundamental
- Price
- CMPX $3.74
- GLDG $1.34
- Analyst Decision
- CMPX Strong Buy
- GLDG Strong Buy
- Analyst Count
- CMPX 7
- GLDG 2
- Target Price
- CMPX $14.71
- GLDG $3.50
- AVG Volume (30 Days)
- CMPX 1.7M
- GLDG 4.2M
- Earning Date
- CMPX 11-10-2025
- GLDG 10-10-2025
- Dividend Yield
- CMPX N/A
- GLDG N/A
- EPS Growth
- CMPX N/A
- GLDG N/A
- EPS
- CMPX N/A
- GLDG N/A
- Revenue
- CMPX N/A
- GLDG N/A
- Revenue This Year
- CMPX N/A
- GLDG N/A
- Revenue Next Year
- CMPX N/A
- GLDG N/A
- P/E Ratio
- CMPX N/A
- GLDG N/A
- Revenue Growth
- CMPX N/A
- GLDG N/A
- 52 Week Low
- CMPX $1.27
- GLDG $0.71
- 52 Week High
- CMPX $4.86
- GLDG $1.80
- Technical
- Relative Strength Index (RSI)
- CMPX 45.88
- GLDG 45.92
- Support Level
- CMPX $3.63
- GLDG $1.26
- Resistance Level
- CMPX $4.27
- GLDG $1.41
- Average True Range (ATR)
- CMPX 0.29
- GLDG 0.10
- MACD
- CMPX -0.08
- GLDG -0.04
- Stochastic Oscillator
- CMPX 8.94
- GLDG 15.31
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.